OLABIR 150MG (30) TABLETS
Olaparib Tablets 150mg (Pack of 30 tab.)
Olabir 150mg (30 Tablets)
Composition: Olaparib 150mg
Classification: Anti-cancer medicine (PARP Inhibitor)
What is Olabir 150 (Olaparib) Tablets?
Olabir 150mg contains Olaparib 150mg, manufactured by Aprazer Healthcare. Available worldwide, it is a targeted therapy medicine widely prescribed for maintenance treatment in various cancers.
Aprazer Healthcare – Oncology Orals Manufacturer
At Aprazer Healthcare, we specialize in manufacturing high-quality oncology products. Recognized as a leading oncology orals manufacturer, we export a wide range of anticancer medicines globally, including chemotherapy, targeted therapy, and hormonal therapy formulations.
Uses of Olabir 150 (Olaparib) Tablets
Olabir 150mg is indicated for the treatment and maintenance of:
- Breast Cancer (BRCA-mutated)
- Ovarian Cancer (Advanced or recurrent BRCA-mutated)
- Pancreatic Cancer (Metastatic BRCA-mutated)
- Prostate Cancer (Metastatic castration-resistant)
Mechanism of Action
Olabir (Olaparib) blocks the DNA repair mechanism by inhibiting the PARP (poly ADP-ribose polymerase) enzyme. In cancer cells with faulty BRCA-1 and BRCA-2 genes, inhibiting PARP prevents damaged DNA repair and triggers targeted cell death (apoptosis).
Side Effects
Common side effects include weakness, reduced blood count, diarrhea, lightheadedness, mild cough, shortness of breath, and mouth ulcers.
Serious side effects: Severe anemia, lung inflammation (pneumonitis), deep vein thrombosis, leg swelling, chest pain, and elevated heart rate.
Precautions & Warnings
Olabir is a prescription-only medicine. Avoid use during pregnancy and breastfeeding. Exercise caution in patients with existing blood disorders, liver/kidney dysfunction, or lung disorders.
Important Function Monitoring
Regular monitoring during treatment is required for:
- Complete Blood Count (CBC)
- Renal (Kidney) Functions
- Hepatic (Liver) Functions
- Respiratory & Lung Functions
- Tumor Progression
Drug Interactions
Do not combine Olaparib with strong CYP3A inhibitors/inducers, including certain HIV medicines, antifungal drugs, antibiotics, antidepressants, or anticonvulsants without medical guidance.
Additional information
| Brand | Aprazer Healthcare Pvt Ltd |
|---|
FAQ
